Søgeresultater - X. Cynthia

Refine Results
  1. 1
    Letrozole in the neoadjuvant setting: the P024 trial

    Letrozole in the neoadjuvant setting: the P024 trial af Matthew J. Ellis, X. Cynthia

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  2. 2
    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy

    Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy af Parvin F. Peddi, Matthew J. Ellis, X. Cynthia

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics

    Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics af X. Cynthia, James W. Janetka, Helen Piwnica‐Worms

    Udgivet 2010
    Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

    Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer af Sandeep Rajput, Nimmish Khera, Zhanfang Guo, Jeremy Hoog, Shunqiang Li, X. Cynthia

    Udgivet 2016
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians

    Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians af Foluso O. Ademuyiwa, Tao Yu, Jingqin Luo, Katherine N. Weilbaecher, X. Cynthia

    Udgivet 2016
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old

    Breast cancer stage variation and survival in association with insurance status and sociodemographic factors in <scp>US</scp> women 18 to 64 years old af Christine D. Hsu, Xiaoyan Wang, David V. Habif, X. Cynthia, Kimberly Johnson

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor

    <i>HER2</i>-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2/EGFR Tyrosine Kinase Inhibitor af Noa Ben-Baruch, Ron Bose, Shyam M. Kavuri, X. Cynthia, Matthew J. Ellis

    Udgivet 2015
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models

    Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models af Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, X. Cynthia

    Udgivet 2013
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

    Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. af Dror I. Baruch, J A Gormely, X. Cynthia, R J Howard, B L Pasloske

    Udgivet 1996
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy

    Association of PET-based estradiol-challenge test for breast cancer progesterone receptors with response to endocrine therapy af Farrokh Dehdashti, Ningying Wu, X. Cynthia, Michael Naughton, John A. Katzenellenbogen, Barry A. Siegel

    Udgivet 2021
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining

    Protein Subcellular Localization Profiling of Breast Cancer Cells by Dissociable Antibody MicroArray (DAMA) Staining af Fu, Guanyuan, Song, X. Cynthia, Yang, Xufen, Peng, Tao, Wang, Yingjian, Zhou, G. Wayne

    Udgivet 2010
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  12. 12
    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

    Cost–effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice af Schackman, Bruce R, Haas, David W, Park, Sanghee S, Li, X Cynthia, Freedberg, Kenneth A

    Udgivet 2015
    Få fuldtekst Få fuldtekst Få fuldtekst
    Text
    Føj til favoritter
    Saved in:
  13. 13
    US breast cancer mortality trends in young women according to race

    US breast cancer mortality trends in young women according to race af Foluso O. Ademuyiwa, Feng Gao, Hao Lin, Daniel Morgensztern, Rebecca Aft, X. Cynthia, Matthew J. Ellis

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer

    Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer af Beomyoung Cho, Yunan Han, Min Lian, Graham A. Colditz, Jason D. Weber, X. Cynthia, Ying Liu

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Response

    Neoadjuvant Chemotherapy Is Associated with Improved Survival Compared with Adjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer Only after Complete Pathologic Resp... af Carla S. Fisher, X. Cynthia, William E. Gillanders, Rebecca Aft, Timothy J. Eberlein, Feng Gao, Julie A. Margenthaler

    Udgivet 2011
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

    Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer af César Sánchez, X. Cynthia, Robert J. Crowder, Therese Guintoli, Chanpheng Phommaly, Feng Gao, Lin Li, Matthew J. Ellis

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

    Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells af Venkataswarup Tiriveedhi, Timothy P. Fleming, Peter S. Goedegebuure, Michael Naughton, X. Cynthia, Craig Lockhart, Feng Gao, William E. Gillanders, T. Mohanakumar

    Udgivet 2012
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs

    Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs af Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Philip Miller, X. Cynthia, Richard A. Grucza

    Udgivet 2021
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma

    Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma af X. Cynthia, Martha Q. Lacy, John F. Rompala, Angela Dispenzieri, S. Vincent Rajkumar, Philip R. Greipp, Rafaël Fonseca, Robert A. Kyle, Morie A. Gertz

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  20. 20
    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

    Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase... af Harold J. Burstein, Constance Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney, Diana Lake, X. Cynthia, Kimberly Blackwell, Eric P. Winer, Clifford A. Hudis

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: